Skip to main content
Springer Nature Link
Log in

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Choi YY, et al. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older. Journal of Korean Medical Science 36: e318, No. 45, 22 Nov 2021. Available from: URL: http://doi.org/10.3346/jkms.2021.36.e318

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans. Reactions Weekly 1884, 10 (2021). https://doi.org/10.1007/s40278-021-06331-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06331-8